Walmart confirmed to CNBC on Tuesday that it plans to offer over 250 prescription drugs for free to its employees by 2027, including certain insulins, inhalers, and GLP-1 drugs for diabetes treatment. This move is part of the company's expanded employee benefits, aimed at attracting and retaining talent. Among these, Novo Nordisk's Ozempic and Eli Lilly's Mounjaro will be provided free of charge to patients with type 2 diabetes after a new prior authorization process. However, Walmart will still not cover GLP-1 drugs used for weight loss purposes.